{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:45:47Z","timestamp":1789865147007,"version":"4.0.1"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.eplepsyres.2024.107314","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T00:59:16Z","timestamp":1706835556000},"page":"107314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Efficacy of felbamate in a cohort of patients with epilepsy with myoclonic atonic seizures (EMAtS)"],"prefix":"10.1016","volume":"201","author":[{"given":"Laurel","family":"Reed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ciliberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Nickels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Kossoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Wirrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charuta","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2024.107314_bib1","unstructured":"Cruzan S. Suspension of Felbatol use urged. Washington, DC:Press office, Food and Drug Administration, United States Department of Health and Human Services; August 1, 1994. Google Scholar."},{"issue":"1","key":"10.1016\/j.eplepsyres.2024.107314_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJM199301073280105","article-title":"Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome)","volume":"328","author":"Felbamate Study Group in Lennox-Gastaut Syndrome","year":"1993","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.eplepsyres.2024.107314_bib3","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1212\/WNL.52.8.1540","article-title":"Practice advisory: the use of felbamate in the treatment of patients with intractable epilepsy: report of the Quality Standards Subcommittee of the American Academy of\u00a0Neurology and the American Epilepsy Society","volume":"52","author":"French","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2024.107314_bib4","unstructured":"Hanrahan B., Carson RP. Felbamate. [Updated 2022 Aug 22]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK539799\/."},{"key":"10.1016\/j.eplepsyres.2024.107314_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.seizure.2020.11.017","article-title":"Results of an international Delphi consensus in epilepsy with myoclonic atonic seizures\/ Doose syndrome","volume":"85","author":"Joshi","year":"2021","journal-title":"Seizure"},{"issue":"11","key":"10.1016\/j.eplepsyres.2024.107314_bib6","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1469-8749.2010.03744.x","article-title":"Doose syndrome (myoclonic-astatic epilepsy): 40 years of progress","volume":"52","author":"Kelley","year":"2010","journal-title":"Dev. Med Child Neurol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2024.107314_bib7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/epi.16752","article-title":"Epilepsy with myoclonic-atonic seizures (Doose syndrome): clarification of diagnosis and treatment options through a large retrospective multicenter cohort","volume":"62","author":"Nickels","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2024.107314_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.979725","article-title":"Felbamate for pediatric epilepsy-should we keep on using it as the last resort","volume":"13","author":"Rabinowicz","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.eplepsyres.2024.107314_bib9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.yebeh.2016.01.006","article-title":"Evaluating the safety and efficacy of felbamate in the context of a black box warning: a single center experience","volume":"56","author":"Shah","year":"2016","journal-title":"Epilepsy Behav."},{"issue":"6","key":"10.1016\/j.eplepsyres.2024.107314_bib10","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/epi.17241","article-title":"International league against epilepsy classification and definition of epilepsy syndromes with onset in childhood: position paper by the ILAE task force on nosology and definitions","volume":"63","author":"Specchio","year":"2022","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.eplepsyres.2024.107314_bib11","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.pediatrneurol.2010.02.013","article-title":"Efficacy of felbamate in the treatment of intractable pediatric epilepsy","volume":"42","author":"Zupanc","year":"2010","journal-title":"Pediatr. Neurol."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121124000299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121124000299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:50:17Z","timestamp":1760277017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121124000299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":11,"alternative-id":["S0920121124000299"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2024.107314","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of felbamate in a cohort of patients with epilepsy with myoclonic atonic seizures (EMAtS)","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2024.107314","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107314"}}